Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Diabetic Foot Ulcers (DFUs)Chronic Wound of the Lower Limb (Leg Ulcer or Foot Ulcer)
Interventions
DEVICE

Miro3D Wound Matrix

Miro3D is a sterile, acellular, three-dimensional biologic wound matrix derived from porcine liver via perfusion decellularization and drying. It is trimmed to fit the wound and rehydrated with sterile saline or Lactated Ringer's solution before application. It provides a porous scaffold to support granulation and healing in chronic or post-surgical wounds.

OTHER

Standard of Care (SOC)

SOC includes standard wound care practices such as wound cleansing, debridement, infection management (if applicable), use of protective dressings (e.g., Aquacel or foam covered with Adaptic), and offloading devices (e.g., Foot Defender boot) to relieve pressure on the wound.

Trial Locations (1)

33321

RECRUITING

Barry University Clinical Research, Tamarac

All Listed Sponsors
collaborator

Barry University

OTHER

lead

Reprise Biomedical, Inc.

INDUSTRY